Illinois Appeals Court Affirms Dismissal Of Non-Brand Defendants In Zantac Case
CHICAGO — Claims against non-brand defendants in a woman’s case alleging that the heartburn drug Zantac and its generic equivalent, ranitidine, caused her to develop colon cancer were properly dismissed, an...To view the full article, register now.
Already a subscriber? Click here to view full article